Buradasınız

Anasayfa » Content

POSTTRANSPLANT DİYABETES MELLİTUS

POSTTRANSPLANT DIABETES MELLİTUS

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 1995

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
In this study, we investigated the prevalence, the probable risk factors and the clinical course of post transplant diabetes mellitus (PTDM). In the June of 1994, we found 15 (6 %) PTDMpa¬tients among 225 renal allograft recipients. The mean appearance time of PTDM was 3.2 ±2.8 months. Five of them were treated by diet only, 6 received oral an-tidiabetic drugs and 4 needed insulin. The fifteen PTDM patients were compared with 30 control cases randomly selected. Of the parameters investigated, only age and cumulative cyclosporin do¬se were identified as risk factors (p<0.001 and p<0.05 respectively). There was no statistically signi¬ficant difference between the two groups with regard to the following parameters age, diabetic family his¬tory; serum creatinine value and body mass index at time of the diagnosis of PTDM, the increase in body weight from the time of transplantation to the appea¬rance time of PTDM, cumulative doses of steroid. 22J±18 months after PTDM diagnosis, there was no statistically significant difference between the two groups' creatinine values (1.69±0.62 - 1.51+0.38 mgldL; 149.3+54.8 - 133.4+33.5mmollL). PTDM did not appear to have any harmful effect on graft functi¬on in short term, but increased the predisposition to the urinary tract infection.
Bookmark/Search this post with
Abstract (Original Language): 
Bu çalışmada, merkezimizde izlenen renal allog-reft alıcılarında posttransplant diyabetes mellitus (PTDM)un prevalansı, olası risk faktörleri ve klinik seyri araştırılmıştır. Haziran 1994 'te, toplam 225 hasta arasında, 15 (% 6.6) PTDM olgusu ayırdedildi. PTDMun ortaya çıkış zamanı ortalama 3.2+2.8 ay idi. Beş hasta yal¬nızca diyabetik diyet alırken, 6 hasta oral antidiyabe-tik, 4 hasta ise insülin kullanıyordu. PTDM'lu 15 olgu ve rastgele seçilmiş 30 kontrol olgusu yaş, diyabetes mellitus soygeçmişi; PTDM saptandığı andaki kreatinin değeri, vücut kütle indek¬si; PTDM ortaya çıkana dek geçen posttransplant sü¬re içindeki ağırlık artışı, prednisolon ve siklosporinin kümülatif dozları açısından karşılaştırıldı. Bu parametrelerden yalnızca yaş ve kümülatif sik-losporin dozu PTDM için risk faktörü olarak belirlen¬di (p<0.001 ve p<0.05); diğerleri açısından iki grup arasında fark yoktu. PTDM teşhisinden ortalama 22 ± 18 ay sonra, iki grubun kreatinin değerleri arasında istatistiksel ola¬rak anlamlı bir farklılık bulunmadı; buna karşın PTDM grubunda üriner traktüs enfeksiyonu epizodu¬nun daha sık oluşu dikkat çekiciydi.
FULL TEXT (PDF): 
PDF icon pdf_tndt_72.pdf
  • 1
17-20
  • Turkish

REFERENCES

References: 

1. Starzl TE, Marchioro TL, Rifkind D, et al. Factors in succesful renal transplantation. Surgery 1964; 56: 293¬318.
2. Me Geown MG, Douglas JF, Brown WA et al. Advanta¬ges of low dose steroid from the day after transplantati¬on. Transplantation 1980; 29: 287-289.
3. Gunnarson R, Arner P, Lundgren G et al: Diabetes M elli -
tus-a more common than believed complication of renal transplantation. Transplant Proc 1979; 11: 1280-1281.
4. Friedman EA, Shyh T, Beyer MM et al. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985; 5: 196-202.
5. Boudreaux JP, Me Hugh L, Canafax MD, et al. The im¬pact of cyclosporine and combination immunosuppressi-on on the incidence of posttransplant diabetes in renal al-lograft recipients. Transplantation 1987; 44: 376-381.
6. Butt KMH, Parsa J, Emett L et al. Antithymocyte globu¬lin-related diabetes in living related transplantation.
Transp Proc 1983; 15: 1083-1085.
7. Roth D, Milgrom M, Esquenazi V et al. Posttransplant hyperglycemia: Increased incidence in cyclosporine trea¬ted renal allograft recipients. Transplantation 1989; 47:
278-281.
8. Yagisawa T, Takahashi K, Teraska S et al. Deterioration in glucose metabolism in cyclosporine-treated kidney transplant recipients and rats. Transp Proc 1986; 18: 1548-1551.
9. Von Kiparski A, Frei D, Uhlschmid G et al. Posttrans-plant diabetes mellitus in renal allograft recipients: A matched pair control study. Nephrol Dial Transp 1990;
5: 220-225.
10. Gunnarson R, Lundgrin G, Magnusson G et al. Steroid diabetes: A sign of overtreatment with steroids in renal
graft recipients ? Scand J Urol Nephr 1980; 54: 135-138.
11. Ruiz JO, Simmons RL, Callender CO, et al. Steroid dia¬betes in renal transplant recipients: Pathogenetic factors and prognosis. Surgery 1973; 73: 759-765.
12. Basri N, Aman H, Adiku W, et al. Diabetes mellitus after renal transplantation. Transplant Proc 1992; 24: 1780¬1781.
13. Rao M, Jacob CK, Shastry JCM. Post-renal transplant di¬abetes mellitus-a retrospective study. Nephrol Dial
Transplant 1992; 7: 1039-1042.
14. Yoshimura N, Nakai I, Ohmori Y et al. Effect of cyclos-porine on the endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 1988; 12: 11-17.
15. David DS, Cheigh JS, Braun DW el al. HLA-A 28 and steroid induced diabetes in renal transplant patients. JA¬MA 1980; 243: 532-533.
16. Hahn HJ, Jaube F- Lucke S et al. Toxic effect of cyclos-porine on the endocrine pancreas of Wistar rats. Trans¬plantation 1986; 41(1): 44-47.
17. Gunnarson R, Klintmalm G, Lundgren G et al. Deteriora¬tion in glucose metabolism in pancreatic transplant reci¬pients after conversion from azathioprine to cyclospori-
ne. Transplant Proc 1984; 16(3): 709-712.

Thank you for copying data from http://www.arastirmax.com